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1. Introduction 
The early postoperative course for most patients after cardiac surgery is characterized by a 
typical pattern of pathophysiologic derangements that benefits form standardized care. 
Multimodal, multidisciplinary standardization of the care process has been shown to 
improve use of resources, efficiency, quality, safety and patient satisfaction. 
The initial management in the postoperative care after routine cardiac surgery has 
fundamentally shifted during the past two decades towards a more efficient use of limited 
postoperative care facilities, early extubation and rapid discharge. The fast-track protocol 
became feasible after cardiac surgery due to improvements in perioperative anaesthesia 
management, new surgical techniques, better myocardial protection and cardiopulmonary 
bypass techniques and to better management of bleeding using point-of-care testing and 
new hemostatic drugs. 
This chapter will briefly discuss the major pathophysiologic derangements and their 
management during the first 24 hours after surgery. It will than summarize the 
postoperative care to more specific procedures. Finally, the management of common 
postoperative complications will be discussed. 
2. Pathophysiology during the early postoperative period 
Arrival in the intensive care unit 
Upon arrival in the ICU, an efficient transfer of care from operation room staff to ICU staff is 
mandated, while at the same time vital signs are to be maintained stable. 
The initial goals in postoperative cardiac recovery are sufficient analgesia, normothermia, 
adequate oxygenation and ventilation, control of bleeding, restoration of intravascular 
volume, optimization of blood pressure and cardiac output to maintain organ perfusion and 
metabolic stabilization. 
Hypothermia 
Hypothermic cardiopulmonary bypass is usually terminated after the patient has rewarmed 
to a core body temperature of at least 36 C. (1) However, patients usually arrive in the ICU 
with lower core temperatures. This drop in temperature from end of CPB until arrival in the 
ICU is due to the cool ambient temperatures in the operation room, poor peripheral 
perfusion and anesthesia-induced inhibition of normal themoregulation. Even patients 
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operated under normothermic CPB, have a tendency to significantly cool down before 
conclusion of surgery. 
Hypothermia has many potential adverse effects. (2) It increases the systemic vascular 
resistance (SVR) which increases myocardial afterload and myocardial oxygen demand. This 
compensatory mechanism to provide core warming may contribute to slow warming of 
peripheral tissues. Drugs that provide vasodilation may improve peripheral  perfusion. To 
prevent hypotension, warmed infusions should be administered concomitantly. Peripheral 
vasodilation augments heat loss, and core hypothermia may therefore persist. 
Hypothermia also precipitates shivering, thereby increasing CO2 production and oxygen 
consumption, and predisposes to ventricular arrhythmias and coagulation cascade 
impairments. (3,4) 
Therefore, warming should be hastened by forced-air warming blankets, heated humidifiers 
in the ventilator circuit and warmed infusion fluids. The use of other types of warming 
blankets or radiant heading hoods can also be considered. (5) 
After cardiac surgery, patients may rapidly rewarm and occasionally overwarm to higher 
temperatures. This phenomenon is attributed to the resetting of the central 
thermoregulation system. 
Blood loss after cardiac surgery 
Careful hemostasis in the operation room is the cornerstone in reducing postoperative blood 
loss. However, bleeding can also be medical and determing the cause of bleeding is often 
difficult. Although the clinical situation must be individualized for each patient, bleeding in 
general should not exceed 400 mL/hr during the first hour, 200 mL/hr for each of the first 2 
hours, or 100 mL/hr over the first four hours. (6) 
There are numerous medical causes for bleeding following cardiac surgery. Residual 
heparinization is common post cardiac surgery and usually occurs when insufficient 
protamine is used or heparined pump blood is transfused following CPB. 
Platelet dysfunction is also common following cardiac surgery. The CPB circuit itself leads 
to contact activation and degranulation of platelets, resulting in their dysfunction. 
Fibrinolysis frequently occurs after CPB, caused by activation of inflammatory or 
coagulation pathways. 
Coagulation factors may decrease from activation and dilution in the CPB circuit. 
There has been a dramatic increase in the iatrogenic use of heparin and newer antiplatelet, 
antithrombotic and thrombolytic drugs during (interventional) treatment of acute cornary 
syndromes. If revascularization surgery is warranted immediately after these treatments, 
the anticoagulant effect of these drugs is notable in the postoperative period.  
Conventional coagulation tests are helpful to identify the coagulation abnormality 
contributing to the bleeding. Common laboratory testing includes Hb, platelet count, aPTT, 
INR, and fibrinogen level. Thromboelastography is also commonly used and has been 
demonstrated to reduce transfusion requirements. 
The most basis principles of the management of postoperative bleeding are: 
1. Diagnose underlying medical cause by coagulation tests; 
2. Rule out surgical bleeding; 
3. Restore clotting parameters to normal by means of medications , transfusion of blood 
products or clotting factors, and restore normothermia; 
4. Monitor for stability of clotting parameters. 
www.intechopen.com
 
Early Postoperative Care After Cardiac Surgery 
 
127 
Most cardiac surgical centers use the antifibrinolytic lysine analogues, tranexaminic acid 
and aminocaproic acid, to reduce intraoperative bleeding. These drugs significantly reduce 
allogeneic blood transfusion after cardiac surgery.  
Although  rescue therapy with recombinant factor VII can be life-saving in massive bleeding 
after cardiac surgery, its safety has been questioned. A recent meta-analysis (N = 4468 from 
35 studies) demonstrated that this therapy significantly increased the rate of arterial but not 
venous thromboembolic events. Given its cost and arterial thrombotic risk, it is likely that 
this hemostatic intervention will continue to be reserved for life-saving therapy of massive 
coagulopathy after cardiac surgery.(7) 
Blood transfusion management 
Although there are guidelines for blood transfusion in cardiac surgery, considerable 
variability has persisted in clinical practice. This variability also exists in anticoagulation 
and coagulation management.  
A recent randomized controlled trial has already demonstrated that restrictive perioperative 
transfusion does not result in inferior clinical outcome after cardiac surgery. (8) Transfusion 
burden may in the future be interpreted as a quality indicator in cardiac surgery that must 
balance risks and benefits to achieve cost-effective optimal clinical outcomes. (9,10) 
Perioperative transfusion algorithms for the administration of blood products, coagulation 
factors and pro-coagulant drugs should assist in preserving resources with improvement in 
patient safety. (11) 
Fluid resuscitation  
Cardiac surgery and CPB elicit a systemic inflammatory response which produces a capillary 
leak. Therefore, fluid resuscitation with cristalloids and/or colloids is necessary to offset the 
hemodynamic consequences of the capillary leak and the vasodilation that occurs from 
rewarming and vasodilating drugs. However, the maintenance of intravascular volume in the 
leakage phase occurs at the expense of expansion of the interstitial space. (12,13) 
After the capillairy leak has ceased and hemodynamics have stabilized, diuretics are often 
used to eliminate the excessive salt and water administered during surgey and the early 
postoperative phase. This forced diuresis may beneficially affect pulmonary function and 
early successful extubation. 
Several intraoperative measures that have been implemented throughout the years caused a 
reduction in the inflammatory response and may have contributed to the faster recovery 
times currently observed after cardiac surgery. The measures include the use of membrane 
oxygenation, centrifugal pumps, anti-fibrinolytic drugs and steroids, leukocyte filters and 
coated CPB tubings. (14,15) 
Perioperative cardiovascular dysfunction 
Adequacy of organ perfusion and tissue oxygenation is the primary goal of hemodynamic 
management in the postoperative cardiac surgical patient. Preload, afterload and 
contractility should therefore be maintained at their optimal level. This commonly requires 
atrial or atrioventricular pacing. 
Approximately 20 % of cardiac surgical patients develop cardiovascular dysfunction in the 
perioperative period, resulting in an inability to pump sufficient blood at normal end-diastolic 
pressures. There are three distinct clinical scenarios of cardiac impairment in the perioperative 
period of cardiac surgery - precardiotomy, failure to wean and postcardiotomy – differing 
from each other substantially concerning diagnosis, monitoring and management. 
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Precardiotomy heart failure 
Myocardial ischaemia is one of the most frequent causes of precardiotomy low output 
syndrome. The dysfunctional myocardium may not be irreversibly damaged and possibly 
only ‘stunned’or ‘hibernating’. Revascularization of the reversibly injured heart areas may 
result in improved cardiac performance. The first priority should therefore be prompt 
surgery avoiding further alterations in myocardial contractility, possibly by introducing an 
IABP preoperatively. However, inadequate myocardial protection during cardiac surgery 
may exacerbate ischaemic injury in some patients. Patients with longer standing previous 
poor preoperative cardiac function or with recently irreversibly injured ischaemic heart 
areas, will of course continue to have poor ventricular performance postoperatively. 
Failure to wean 
For the successful therapeutic approach of failure to wean, a correct diagnosis of the 
underlying cause is necessary. The heart failure may be procedure related or patient specific 
and includes inadequate myocardial protection, reperfusion injury, ischaemia, infarction, 
incomplete revascularization, metabolic, uncorrected pathology, mechanical issues, 
conduction issues, pulmonary hypertension and right ventricular failure. 
Postcardiotomy heart failure 
The priority is to preserve end organ function. Preload and heart rhytm should be 
optimized, and positive inotropic and/or vasopressor drugs are often used to maintain 
adequate cardiac output and blood pressure. Although this strategy will restore 
haemodynamics in most patients, mechanical circulatory support may be indicated. 
Monitoring and assessing volume status 
Heart failure cannot be ascertained unless the volume status is optimal. However, it is 
difficult to ascertain volume loading using single haemodynamic measures. Pressure estimates 
such as pulmonary capillary wedge pressure and central venous pressure are generally 
unreliable indicators of LV and RV preload. Uncoupling between PCWP and LVEDP 
frequently occurs as a consequence of elevated pulmonary vascular resistance, pulmonary 
venoconstriction, mitral stenosis and reduction in transmural cardiac compliance. 
Volumetric estimates by echocardiography or transpulmonary thermal dilution techniques 
are more predictive of preload. In predicting fluid responsiveness in ICU patients, it is 
preferable to use more reliable dynamic indicators reflecting hypovolaemia, such as stroke 
volume variation, than static parameters. (16) Several devices are now being used to assess 
cardiac function based on pulse contour analysis of an arterial waveform. (17) 
Echocardiography is of great value in the perioperative cardiac surgical setting. It not only is 
helpfull in assessing the optimal volume status, but may also immediately identify causes of 
cardiovascular failure, including valvular problems, cardiac tamponade, systolic anterior 
motion of the anterior mitral valve leaflet and pulmonary embolism. Echocardiography may 
differentiate between acute right, left and global heart failure as well as between systolic and 
diastolic dysfunction. 
If there are echocardiographic signs of RV failure, a pulmonary artery catheter (PAC) 
preferably with continuous SvO2 measurement should be introduced. PACs can differentiate 
between pulmonary hypertension and RV ischaemia, which necessitates a reduction of RV 
afterload. PAC and TEE are complementary to each other for diagnosis and treatment of the 
cardiac surgical patient. Indications for the use of a PAC are, high risk and/or complex cardiac 
surgery, hemodynamic instability, low cardiac output syndrome, pulmonary hypertension, 
www.intechopen.com
 
Early Postoperative Care After Cardiac Surgery 
 
129 
differentiating between severe right and left ventriclular dysfunction, 
vasodilation/vasoconstriction, hypovolemia. SvO2 in combination with lactate concentration 
was used postoperative as a goal-oriented hemodynamic therapy to improve outcome.(18,19) 
Risk stratification  
Risk stratification is increasingly used in open-heart surgery to help adjust resources to 
predicted outcome. According to all scoring systems major clinical risks include heart 
failure, unstable coronary syndromes, significant arrhythmias and severe valvular disease. 
The euroSCORE is mostly used to calculate operative risk, although updating its sensitivity 
is warranted. (20,21) 
In addition to scoring systems, levels at hospital admission of B-type natriuretic peptide (BNP) 
and the amino-terminal fragment of pro-BNP (NT pro-BNP) are powerful predictors of 
outcome with regard to in-hospital mortality and rehospitalisation in heart failure patients. (22) 
Perioperative myocardial protection  
The ultimate goal of perioperative myocardial protection is to limit the extent and 
consequences of myocardial ischaemia-reperfusion injury. This injury is caused by free 
radical formation, calcium overload and impairment of the coronary vasculature. Protective 
measures include the use of free radical oxygen scavengers, inhibitors of the complement 
system and neutrophil activation, modulation of intracellular gradients and maintenance of 
sufficient myocardial high energy phosphate stores. Drugs affecting the complement-
inflammation pathways, adenosine modulators, cardioplegia solution adjuvants, Na+/H+ 
exchange inhibitors, KATP channel openers such as volatile anaesthetics and levosimendan, 
and anti-apoptotic agents are all used for this purpose. (23,24) 
Pharmacologic support of myocardial dysfunction 
Pharmacological treatment of low cardiac output and reduced oxygen delivery to vital 
organs is often required in the perioperative cardiac surgical setting. Inadequate treatment 
may lead to multiple organ failure, one of the main causes of prolonged hospital stay, 
postoperative morbidity and mortality. Optimal use of inotropes and vasopressors is still 
controversial and needs further large multinational randomized controlled trials.  
However, some recommendations can be made: 
- Norepinephrine should be used in case of low blood pressure due to vasoplegia to 
maintain an adequate perfusion pressure. Preload should be assessed regularly to avoid 
hypovolemia under vasopressors. 
- All catecholamines have positive inotropic and chronotropic effects. There is evidence 
that dobutamine better preserves the myocardial oxygen balance as compared to the 
other commonly used drugs. Dobutamine increases stroke volume and heart rate while 
PCWP is moderately decreased. If blood pressures are low, the combination 
dobutamine-norepinephrine is frequently used. 
- Phosphodiesterase III inhibitors are potent vasodilators and cause less 
tachyarrhythmias as compared to dobutamine. They also have a more favourable effect 
on the myocardial oxygen balance as compared to the catecholamines. 
- Levosimendan, a calcium sensitizer, has recently been introduced for the treatment of 
low cardiac output in the perioperative period with success. (25,26,27,28) 
Mechanical circulatory support 
The intra-aortic balloon pump (IABP)  is recommended in the case of heart dysfunction with 
suspected coronary hypoperfusion. It’s main mechanism of action is a reduction of afterload 
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and diastolic coronary perfusion pressure. The IABP reduces heart work and myocardial 
oxygen consumption, favourably modifying the balance of oxygen supply/demand. 
Extra-corporeal membrane oxygenation (ECMO) is increasingly used for temporary mechanical 
circulatory support. Advantages of the system include low cost, availability in all cardiac 
surgical centers and versatile use for cardiac, pulmonary and renal support. ECMO is used as a 
bridge to recovery, to transplantation, to long-term assist-device and to decision making. 
Ventricular assist devices are used today as an established option for patients with end-stage 
heart failure to obtain a level of functionality that results in an acceptable quality of life for 
the patient. 
Cardiac arrhythmias 
Temporary pacing 
Two temporary right atrial and two right ventricular epicardial pacing wire electrodes are 
usually placed at the conclusion of cardiac surgery. Atrial pacing wires can be used 
diagnostically to record atrial activity. These recordings, obtained simultaneously with 
standard limb leads, can distinguish among atrial and junctional arrhythmias and 
differentiate them from more life-threatening ventricular arrhythmias. (6) 
The use of pacing is often required in the per- and postoperative period to increase heart 
rate. Atrial or AV pacing will nearly always demonstrate superior haemodynamics to 
ventricular pacing. Reentrant rhytms can be terminated by rapid pacing.  
Arrhythmias after cardiac surgery  
The development of cardiac arrhythmias following open-heart surgery is fairly common and 
related to altered impulse formation and conduction. An understanding of these 
mechanisms and the electrophysiologic effects of antiarrhythmic drugs provides a rational 
basis for the treatment of the different rhythm disturbances. 
Atrial fibrillation 
Despite various prophylactic measures, atrial fibrillation and flutter occur in about 35 % of 
all cardiac surgical patients, most commonly on the second and third postoperative day. 
Etiologic factors include atrial distension, pericardial inflammation, enhanced sympathetic 
activity, surgical trauma and poor atrial preservation.  
To prevent atrial fibrillation, ß-blockers with or without class III ( Sotalol) antiarrhythmic 
properties, are commonly administered orally in the perioperative phase. Dual site atrial 
pacing and numerous other medications (amiodarone, magnesium sulphate, triodothyronine, 
digoxin, steroids, procainamide, verapamil, diltiazem) have all been reported to have some 
favourable effect on the incidence of atrial fibrillation after cardiac surgery. 
Treatment consists of  cardioversion in the haemodynamically unstable patient. For the 
stable patient, rate control and attempts to achieve conversion are usually initiated. Drugs 
used for rate control include calcium-channel blockers (diltiazem, verapamil), ß-blockers 
(esmolol, metoprolol), magnesium sufate and digoxin. For conversion to sinus rhythm, 
magnesium sulphate, IA medications (procainamide, quinidine) , IC (propafenone) or III 
antiarrhythmics (Ibutilide, Amiodarone) are commonly used. (29,30,31) 
Ventilation management 
Pulmonary complications following cardiac surgery are common, even in patients with 
healthy lungs, and include diminished functional residual capacity (FRC) following general 
anaesthesia and muscle relaxants, reductions in vital capacity (VC) following median 
www.intechopen.com
 
Early Postoperative Care After Cardiac Surgery 
 
131 
sternotomy and intrathoracic manipulation, atelactasis, increased intravascular lung water, 
and increased capillary leakage and extravascular lung water due to the inflammatory 
response to CPB and surgery. Multiple blood product transfusions and excessive fluid 
loading may further compromise lung functioning. Acute FRC reduction results in arterial 
hypoxemia due to ventilation-perfusion mismatch and shunting. In the early postoperative 
phase, restoration of FRC and maintenance of adequate gas exchange in the face of rising 
VO2 and VCO2 are the primary goals. This can be achieved by a lung-protective ventilation 
strategy with adequate levels of PEEP. (32,33,34) 
For several decades, the medical care of the cardiac surgical patients in the perioperative 
setting consisted of high-dose opioid stress-free anaesthesia and prolonged mechanical 
ventilation in the ICU. In recent years, the concepts of Fast-Track Cardiac Anesthesia, Early 
Extubation and Short-Stay Intensive Care became the backbone of modern perioperative 
care. Indeed, several randomized trials have shown the safety of fast-tracking. 
(35,36,37,38,39) 
Alterations in anaesthetic protocols using short-acting sedatives-hypnotics and analgesics, 
less invasive surgical and perfusion techniques, improved perioperative haemostasis 
management, fluid restriction, preservation of normothermia and reduction of the 
inflammatory response were all crucial steps in the development of fast-track cardiac 
surgery. As the number of elderly people is growing fast and cardiac surgery is now an 
accepted practice in these older patients, fast-tracking makes it possible to more efficiently 
use the limited facilities and resources. (40) 
The debate regarding the optimal extubation time, the window of opportunity, is still ongoing. 
(41) There are several studies on outcome after extubation in the operation room, which show 
that it is feasible with good results.(42, 43) However, the nadir of ventricular function occurs 
about 4 hours following cardiopulmonary bypass. Also, the first few hours after cardiac 
surgery are characterized by periods of haemodynamic instability, temperature dysregulation, 
increased mediastinal blood loss and other homeostatic disturbances. Patients can rapidly 
deteriorate in this early postoperative phase and we believe that instabilities can be best 
anticipated and treated in an ICU setting in sedated and ventilated patients. The window of 
opportunity for extubation is therefore between 2 and 6 hours postoperatively. 
Weaning strategies should be protocolized.(44) In table 1 is shown a nurse-driven weaning 
protocol which includes the criteria for the start of the weaning procedure, adequate 
breathing criteria and the extubation criteria. Only three steps in this protocol may mandate 
the consultation of the ward doctor. 
After ventilatory weaning, the next step in the postoperative ICU management is the 
discharge of the patient to a  step-down unit. This is usually accomplished within 8 hours 
after arrival in the ICU. Intensive Care discharge criteria are shown in Table 2.  
The postoperative (intensive) care unit 
The advent of Fast-Track Cardiac Anaesthesia and Short-Stay Intensive Care after Cardiac 
Surgery also started the discussion whether or not these patients should be treated in a 
conventional ICU setting. Can adequate and safe postoperative care be given to these patients 
in parallel “special-care units” such as a dedicated Cardiac Recovery Area (CRA). If a hospital 
has such a highly-equipped special care unit with a competent and qualified ICU doctor on the 
ward, adequate nurse-patient ratio and immediate access to ICU-OR facilities, then special care 
may be feasible. Several institutions reported safe and adequate care in these special units. 
(45,46) However, in the early postoperative phase, the clinical condition of the patient may  
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Table 1. Weaning protocol 
 
 
Table 2. ICU Discharge Criteria 
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deteriorate extremely rapidly. Therefore, continuous adequate monitoring and maximal 
acute treatment or intervention should always be readily possible for these patients in the 
early postoperative period. We believe that currently in most hospitals, the ICU setting is 
the safest and best place to recover from cardiac surgery. In the integrated model, in which 
all patients are admitted to the ICU, the postoperative management such as nursing-to-
patient ratio is variable based on patient requirements. The goal is thus a postoperative unit 
that allows variable levels of monitoring and care based on patient need. In this model, 
discharge to a step-down unit as soon as possible after extubation and stabilization of vital 
parameters should be strived after for every single patient.  
Postoperative anticoagulation 
After coronary artery surgery, antiplatelet therapy has been shown to inhibit platelet 
deposition on vein grafts and may delay or attenuate the development of fibrointimal 
hyperplasia and atherosclerosis. Aspirin should therefore be started after CABG surgery 
and continued indefinitely because of its beneficial effects in patients with native coronary 
disease. (47) 
After tissue aortic valve surgery, there is some evidence that short-term anticoagulation may 
reduce the incidence of thromboembolism. Therefore, anticoagulation is generally 
recommended for 3 months in younger patients or those with no contraindication for 
anticoagulation, and is then converted to aspirin. If anticoagulation is not used, aspirin is 
given. (48,49) 
After mechanical aortic valve surgery, all patients should receive anticoagulation 
indefinitely to achieve an INR of 2.5 – 3.5 for tilting and bileaflet valves.  
After mitral tissue valve or mitral ring implantation, anticoagulation should be given for 3 
months to achieve an INR of 2.0 – 3.0 and should then be converted to aspirin if the patient 
is in sinus rhythm. Anticoagulation should be continued indefinitely in patients with atrial 
fibrillation, an enlarged left atrium (> 50 mm in diameter), or a history of thromboembolism. 
After mechanical mitral valve insertion, anticoagulation is given to achieve an INR of 2.5 – 
3.5. The addition of aspirin is safe and may further reduce the thromboembolic risk. (50,51) 
Echocardiography 
During the past few decades, the effect of perioperative transoesophageal 
echocardiography’s (TEE) influence on perioperative cardiac surgical decision making has 
become increasingly more appreciated. Data from several clinical investigations have 
consistently implicated an important, clinically significant, and cost-effective role for TEE as 
a safe and valuable haemodynamic monitor in identifying high-risk patients, in assessing in 
the determination of the definitive surgical approach, and in providing a timely post-
cardiopulmonary bypass evaluation of the procedure, thereby allowing for the opportunity 
to immediately re-intervene or to at least triage patients appropriately. In addition, 
perioperative TEE has been instrumental in diagnosing cardiac and associated great vessel 
pathology and in identifying structural abnormalities, aortic disease, intracardiac masses, 
and pericardial disease. TEE is perhaps most useful for the perioperative evaluation of 
cardiac valvular disease, especially during surgical procedures involving the mitral valve.  
In the intra- and early postoperative period of cardiac surgery, an experienced 
echocardiographer remains an indispensable clinical team member. Increasing numbers of 
cardiac anaesthesiologists and intensivists are now being trained and certified as 
perioperative echocardiographers. (52,53,54) 
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Analgesia and sedation 
An essential element of postoperative care is the provision of adequate analgesia and 
sedation. In the patient in whom delayed extubation is anticipated, the residual effects of 
anesthetics and midazolam in combination with a narcotic are generally accepted. 
With the trend toward earlier extubation, short-acting narcotics and analgesics are 
administered during surgery. This requires early postoperative administration of short-
acting medications for pain relief and sedation. We prefer to give low dose continuous 
infusions of morphine in combination with propofol in the ICU. This usually produces 
adequate sedation and pain relief without respiratory depression and allows for fairly early 
extubation. 
3. Management after specific cardiac surgical procedures 
Coronary Artery Bypass Grafting 
Treatment of coronary artery disease can be medical or interventional. Catheterization 
procedures include balloon angioplasty, cardiac stenting and drug-eluding stents, which 
release drugs capable of preventing stenosis. Surgery includes CABG with the use of the 
cardiopulmonary bypass machine and OPCAB without the use of the CPB machine. OPCAB 
surgery may include sternotomy, thoracotomy (MIDCAB) or robotically assisted 
thoracotomy. 
With increasing number of treatment options, it is crucial to establish for each patient which 
option is superior with regard to angina recurrence, graft patency, and long term survival 
with the least morbidity at the lowest costs. Several studies address this important issue. 
Analysis of individual patient data from ten randomized trials including 7812 patients 
concluded that long-term mortality after CABG and PCI in most patient subgroups with 
multivessel CAD is similar. (55) CABG versus PCI had lower mortality in diabetes and 
patients older than 65 years. The SYNTAX investigators concluded from their study that in 
low and intermediate risk patients with multivessel CAD, PCI and CABG have similar 
outcomes. In high risk patients with multivessel CAD, CABG is preferred. (56) 
Although the COURAGE study, which provided optimal medical therapy (OMT) to all 
patients  and demonstrated no incremental advantage of PCI on outcomes other than 
angina-related quality of life in stable CAD, a recent analysis by Borden et al reported that 
among patients with stable CAD undergoing PCI, less than half were receiving OMT before 
PCI and approximately two-thirds were receiving OMT at discharge following PCI. (57,58) 
A number of randomized controlled studies comparing OPCAB to on pump CABG have 
been completed. Although outcomes have been largely comparable, the evidence of benefits 
of OPCAB from these trials has not been as convincing as was first anticipated. A large 
adequately powered RCT of OPCAB versus on pump CABG in high risk patients is needed 
to determine whether this undeniably harder technique is here to stay. (59,60,61) 
Aortic Valve Surgery 
Aortic valve replacement surgery may be complicated by heart block because the 
conduction system lies adjacent to the base of the right coronary cusp. If AV pacing is 
necessary for more than 4 to 5 days, during which time edema or hemorrhage should 
subside, placement of a permanent DDD pacemaker is necessary because the conduction 
system then probably has been damaged by sutures or débridement. 
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The hypertrophied, noncompliant left ventricle in aortic stenosis depends on adequate 
preload and on atrial contractions. Loss of sinus rhythm is associated with a 30 % reduction 
in stroke volume and requires AV pacing. 
In aortic regurgitation, the left ventricle is volume and pressure overloaded resulting in a 
dilated and often hypertrophied chamber. Aortic valve repair for aortic regurgitation is 
evolving into a standard of care. The systematic classification of aortic regurgitation based 
on leaflet mobility within the functional aortic annulus makes it possible to study outcomes 
of the specific interventions. (62,63) 
A recent RCT showed that transcatheter aortic valve implantation (TAVI) is significantly 
superior to medical management of severe aortic stenosis in patients judged to be at 
excessive risk for conventional aortic valve replacement. (64) TAVI significantly reduced all-
cause 1-year mortality. Recent studies have documented rates of cerebral embolism of 70-80 
%. (65) Future trials should focus on interventions for stroke reduction after TAVI, including 
cerebral embolic protection. Techniques for reduction of embolic load may also improve 
renal dysfunction after TAVI. Although the short and medium term durability of the TAVI 
valve with preserved hemodynamic performance has been established, further studies are 
required to elucidate the long term effects. (66,67,68) To this term, guidelines for 
standardized endpoints in TAVI trials have been published.(69) 
Mitral valve surgery 
Patients with chronic mitral stenosis often have pulmonary hypertension and usually are 
diuretic-dependent. They have a small left ventricular cavity with preserved LV function. 
Common postoperative problems are a low cardiac output syndrome associated with the 
small LV end-diastolic and end-systolic volumes, RV dysfunction and ventilatory failure 
due to the pulmonary hypertension, cachexia and fluid overload. 
Due to the systolic unloading in patients with mitral valve regurgitation reducing LV wall 
stress, greater systolic wall stress is required after surgery to achieve adequate cardiac 
output. Therefore, the use of inotropic support and afterload reduction is often indicated. 
In the postoperative period, cardiovascular management is often directed toward increasing 
filling pressures to above 15-20 mmHg, reduction of pulmonary hypertension and 
improvement of RV and LV failure. Guiding hemodynamic support with the use of a 
pulmonary artery catheter may be very helpfull. When atrial fibrillation has been present for 
more than 1 year or when LA dimension exceeds 50 mm, it is very unlikey to maintain sinus 
rhythm in the postoperative period. AV pacing is often possible after surgery and may 
improve cardiac performance. (6) 
Diseases of the thoracic aorta 
Multidisciplinary guidelines for thoracic aortic diseases were published in 2010. (70) We will 
highlight some concerns that concern the perioperative setting.  
Ascending aortic dilatation should be carefully measured in patients with a bicuspid aortic 
valve presenting for surgery. Earlier surgical intervention is warranted to avoid rupture or 
dissection. 
In aortic arch aneurysm surgery, hybrid repair has emerged as low risk aortic repair in high-
risk patients. Type I repairs have adequate proximal and distal landing zones: after off-
pump anastomosis of the brachiocephalic vessels to the ascending aorta, an endovascular 
stent is deployed for complete arch repair. Type II repairs have adequate distal landing zone 
but insufficient ascending aorta to serve as a proximal stent landing zone: after ascending 
aortic replacement with aortic arch debranching, an endovascular stent is deployed for 
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complete arch repair with the ascending aortic graft serving as proximal landing zone. Type 
III repairs have inadequate proximal and distal landing zones: after total arch replacement 
with a distal elephant trunk, the descending thoracic aortic repair is completed by 
endovascular stentingwith the elephant trunk serving as the proximal landing zone. 
Concerning aortic dissection, the Penn classification of a type A dissection integrates type of 
clinical presentation with dissection extent to stratify perioperative outcome and facilitate 
decision-making about the type of surgical repair. (71) 
The American Heart Association recently published a position paper on the integrated 
management of decending thoracic aortic disease that complements the recent guidelines 
from the Society of Thoracic surgeons. (72) These guidelines together summarize the 
paradigm shift in the management of descending thoracic aortic pathologies due to 
endovascular therapies. In Stanford type B aortic dissection, the conservative management 
of refractory pain and hypertension is associated with significant short-term mortality. 
Therefore, although a survival advantage has not been demonstrated yet, endovascular 
intervention of these type B dissections is now more often applied.  
Depending on the type of organ protection applied during aortic surgery (deep hypothermic 
circulatory arrest, selective perfusion of brain and kidneys) coagulopathies and neurologic 
deficit may occur. Brain damage may be due to ischemia or embolisation and paraplegia 
may result from crossclamping of the descending aorta. Careful neurologic evaluation 
before and after surgery are important.  
Also, the hypotensive regimen used in the early postoperative period must reduce systolic 
blood pressure and the force of cardiac contraction. The most common regimens include the 
use of beta-blockers. 
4. Management of complications 
Atrial fibrillation 
Atrial fibrillation following cardiac surgery is common and occurs in up to 35 % of patients. 
While the cause of AF is not completely understood, it is associated with an increase in 
mortality, stroke, and prolonged hospital stay. AF has been discussed in Section I of this 
chapter. 
Low cardiac output syndrome 
A low cardiac output state may result from decreased left ventricular preload  
(hypovolemia, cardiac tamponade, vasoplegia), decreased contractility (myocardial 
stunning, ischemia or infarction related to poor intraoperative myocardial protection, 
incomplete myocardial revascularization, anastomotic stenosis, or coronary artery spasm), 
arrhythmias, increased afterload or diastolic dysfunction. 
Transoesophageal echocardiography can help define whether a low cardiac output state is 
related to left ventricular systolic or diastolic dysfunction, right ventricular dysfunction or 
cardiac tamponade. The management of low cardiac output has been discussed in Section I 
of this chapter. 
Right ventricular dysfunction produces inadequate filling of the left heart resulting in a low 
cardiac output state. It may be attributable to poor myocardial protection, prolonged 
ischemic times, coronary embolism, hypotension, RV pressure overload (pulmonary disease, 
ARDS, pulmonary embolism) or acute pulmonary hypertension due to vasoactive 
substances, LV dysfunction, protamine or  hypoxia and acidosis. 
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Right coronary artery disease, right ventricular infarction and pulmonary hypertension 
associated with mitral/aortic disease predispose to RV failure after cardiac surgery. 
PAC’s and TEE are very helpful in assessing the status of the RV function. In the absence of 
LV dysfunction, a high RA/PCWP pressure ratio is suggestive for RV dysfunction. The 
goals of treatment are to optimize RV preload, maintain systemic perfusion pressure, 
improve RV contractility, and reduce RV afterload by reducing pulmonary vascular 
resistance. (27) 
Diastolic dysfunction , defined as increased resistance to filling of one or both cardiac 
chambers, is a common finding after cardiac surgery, especially after cardioplegic arrest. 
Echocardiography has greatly improved the knowledge of diastole by showing the real-time 
activities in the heart, as related to filling pressures, shape and relaxation. Failure of the RV 
can contribute to left-sided diastolic dysfunction by increasing cardiac pressures, which 
causes decreased relaxation of the myocardium yielding decreased myocardial 
distensibility. Factors responsible for increased chamber stiffness include fibrosis, cellular 
disarray, and hypertrophy. Factors responsible for decreased relaxation include asynchrony, 
abnormal loading, ischemia, abnormal calcium ion flux and hypertrophy. Note that 
ventricular hypertrophy affects both stiffness and relaxation, increasing the risk of diastolic 
dysfunction. (73) 
Cardiac tamponade 
Cardiac tamponade is primarily the result of impaired filling of one or more of the cardiac 
chambers and leads to low cardiac output. Adrenergic and endocrine mechanisms are 
activated resulting in tachycardia and vasoconstriction.  
The diagnosis of cardiac tamponade depends on a high degree of suspicion. Tamponade 
after cardiac surgery is different from a medical tamponade due to compressing fluid within 
an intact pericardium. In the setting of cardiac surgery, the pericardial space is often left 
open and in open communication with one or both the pleural spaces, and the compressing 
blood is at least in part clotted and able to cause localized compression of the heart. Serious 
suspicion for tamponade should rise in patients with deteriorating haemodynamics or 
gradually increasing requirements for inotropic drugs. The classic signs of elevated CVP or 
equalization of CVP and PAOP are often absent. Cardiac tamponade is difficult to 
distinguish from biventricular failure. A useful clue may be the pronounced respiratory 
variation of blood pressure in association with high filling pressures and low cardiac output. 
TEE may be helpful in diagnosing cardiac tamponade. Echolucent crescents between the RV 
wall and the pericardium or the posterior LV wall are discernible. A classic sign is diastolic 
collapse of the right atrium or RV. 
A rule of thumb in the acute management of cardiac tamponade is to keep the patient Full, 
Fast and Thight. Full, the delivery of volume expansion in order to achieve an adequate 
preload. Fast, using pacing or medication to increase the heart rate to maintain cardiac 
output since the strokevolume is compromised. Tight, applying vasopressor therapy to 
increase preload, maintain bloodpressure and coronary perfusion pressure. 
The definitive treatment of tamponade is surgical exploration with evacuation of hematoma. 
Renal insufficiency 
No clear definition exists as to what constitutes renal impairment or failure following CPB. 
Renal failure requiring dialysis is infrequent following CPB, although reductions in 
creatinine clearance are more frequent. There are several risk factors for postoperative renal 
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failure, including postoperative low cardiac output, repeat cardiac surgery, valve surgery, 
age greater than 65, and diabetes. 
The primary cause may be prerenal (low pressure, low output, ACE, NSAID’s), renal (Acute 
Kidney Injury) from ischaemic insult or interstitial drug-related nephritis or postrenal.  
Management of these patients consists of supportive treatment ensuring adequate cardiac 
ouput, perfusion pressure and volume status and of determining the primary cause, and 
then directing specific treatment as necessary such as discontinuing the offending drug.  
If patients do require dialysis, continuous dialysis may be better than intermittent dialysis. 
(6,74,75,76) 
Impediments to weaning and extubation 
The most important factors limiting weaning and extubation in the early postoperative 
period after cardiac surgery include: 
1. neurologic dysfunction 
- agitation, restlessness and disorientation may occur after discontinuation of the 
sedative medication. The ethiology of this syndrome is multifactorial and includes 
patient characteristics, perioperative psychotropic drugs used for anaesthesia, pain 
relief and sedation, and  brain ischaemia and inflammation. Initial management consists 
of reassurance and orientation of the patient and control of pain with opioids. 
Resedation for a period or the use of haloperidol may be usefull until the patient is 
oriented and tranquil. 
- diaphragmatic paralysis may complicate cardiac surgery, especially after reoperations, 
due to surgical lesion of the phrenic nerve in fibrotic pericardial tissue. The phrenic 
nerve can also be injured or transected during dissection of the internal mammary 
arteries or during mobilization of the heart in redo surgery. Transient diaphragmatic 
paralysis can also occur secondary to cold injury by the cold cardioplegic solutions to 
the phrenic nerve. (6) 
The diagnosis of diaphragmatic paralysis should be considered whenever a patient fails 
to wean from mechanical ventilation and can be documented by observing paradoxical 
movement of the diaphragm during inspiration. 
2. unstable haemodynamics 
Postoperative cardiac surgical patients with unstable haemodynamics and/or low 
cardiac output syndromes may not well tolerate the extra work of breathing associated 
with weaning. Weaning is difficult and may further deteriorate the already 
compromised myocardium.  
Weaning affects cardiac output due to changes in pulmonary vascular resistance. 
Increased pulmonary vascular resistance (PVR) leads to septal shifts and reduced 
efficiency of biventricular function. It is therefore better to keep the patient sedated on 
full ventilator support until the cardiac problem is resolved. (77) 
3. fluid overload 
Cardiac surgery and CPB result in a systemic inflammatory response syndrome which 
produces a capillary leak. The duration and severity of this syndrome include factors 
related to the patient characteristics, severity of the surgical trauma, administration of 
blood products and CPB management. The use of heparin-coated tubings, membrane 
oxygenator, centrifugal pumps, steroids and leukocyte filters may reduce the SIRS. The 
capillary leak syndrome is usually most predominant the first 6 to 8 hours after the 
termination of CPB. 
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During this period, fluid resuscitation is necessary to offset the capillary leak syndrome 
and the vasodilation secondary to medications and rewarming. Crystalloid and colloid 
infusions are used to maintain intravascular volume, although this usually occurs at the 
expense of expansion of the interstitial space. After the capillary leak has ceased and 
haemodynamics are stable, diuretics contribute to a faster recovery from surgery. 
Succesfull early extubation is compromised by fluid overload. Optimal monitoring and 
adequate measures should therefore be taken in the operation room and in the intensive care 
to minimize the positive fluid balance while maintaining adequate tissue perfusion. (78) 
Central nervous system dysfunction 
Neurologic complications are dreaded sequelae of cardiac surgery. Notwithstanding a 
progressive decrease in cardiac surgical mortality over the past decades, the incidence of 
postoperative neurological complications remains relatively unchanged. 
Focal neurologic complications 
Focal neurologic events complicate approximately 2 % of cardiac procedures requiring CPB, 
but may increase as more patients with advanced age and diffuse vascular disease undergo 
cardiac surgery. Focal deficits may include hemiparesis or hemiplegia, aphasia, dysarthria, 
hand incoordination and visual field deficits. 
Preoperative risk factors include increasing age (risk of up to 10 % in patients older than age 
75), pre-existing cerebrovascular disease, hypertension, peripheral vascular disease, and 
poor LV function. Intraoperative and postoperative risk factors include: ascending aortic 
atherosclerosis and calcification, LV mural thrombus, complex surgery and prolonged 
bypass and haemodynamic instabilities. 
The mechanisms for neurologic injury include some combination of cerebral embolism, 
hypoperfusion, and inflammation; associated vascular disease and cerebral autoregulatory 
dysfunction make the brain more susceptible to injury. Particulate embolism due to 
atherosclerotic plaque, blood thrombus embolus, and air and platelet-fibrin debris is the 
most common cause of stroke. Cerebral hypoperfusion may be the result of systemic 
hypotension or impaired regional cerebral blood flow. Although cerebral autoregulation 
should protect the brain during CPB, hypothermia, blood gas regulation, diabetes and pre-
existing hypertension may affect the adequacy of cerebral autoregulation. (6,79,80,81) 
In the prevention of focal neurologic complications, preoperative evaluation for extracranial 
carotid disease should be considered in any patient with neurologic symptoms. 
Symptomatic carotid disease warrants carotid endarterectomy(CE) prior or at the time of 
cardiac surgery. Asymptomatic carotid disease in the presence of a carotid bruit should be 
evaluated by non-invasive testing. There is a trend toward performance of combined CABG-
CE in these patient groups. (82) 
Intraoperative echocardiograhic scanning of the ascending aorta to identify atherosclerosis 
might alter cannulation sites and clamping - and manipulation techniques of this diseased 
aorta. Techniques to avoid embolic load include the use of membrane oxygenators, arterial 
filters in the CPB circuit, meticulous débridement and irrigation of valves, removal of LV 
thrombi and of air after intracardiac procedures. 
In general, in patients with hypertension or intracranial vascular disease, blood pressure 
during CPB should be maintained at a higher level. 
In the treatment of embolic stroke, heparin is recommended when there is no evidence of 
intracranial hemorrhage on the CT scan. Heparin prevents propagation of intracardiac 
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thrombus and improves cerebral microcirculation, but is of unclear benefit in preventing 
further atheroembolism from dislodged plaque. 
Encephalopathy 
Encephalopathy is fairly common after cardiac surgery and is usually manifested by 
disorientation and confusion, lethargy or agiation, and paranoia and hallucinations. 
The ethiology of this syndrome is multifactorial. It may be related to brain inflammation, 
cerebral hypoperfusion or microemboli from the CPB circuit. Other factors include patient 
characteristics, hypoxia, metabolic disturbaces, perioperative psychotropic drugs used for 
anaesthesia, pain relief and sedation, and drug or alcohol withdrawal. 
Initial management consists of reassurance and orientation of the patient and control of pain 
with opioids. Resedation for a period or the use of haloperidol may be usefull until the 
patient is oriented and tranquil. The encephalopathy has a fluctuating course but is usually 
transient. (79,81) 
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